Bio-Rad Laboratories Inc. (NYSE: BIO) is 4.47% higher on its value in year-to-date trading and has touched a low of $261.59 and a high of $406.44 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The BIO stock was last observed hovering at around $333.71 in the last trading session, with the day’s gains setting it 3.61%.
Currently trading at $337.32, the stock is 4.41% and 9.80% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.21 million and changing 1.08% at the moment leaves the stock 8.82% off its SMA200. BIO registered -15.00% loss for a year compared to 6-month gain of 1.51%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -1.15% loss in the last 1 month and extending the period to 3 months gives it a 17.59%, and is 7.11% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.48% over the week and 3.20% over the month.
Bio-Rad Laboratories Inc. (BIO) has around 8030 employees, a market worth around $9.40B and $2.56B in sales. Fwd P/E is 30.14. Profit margin for the company is -51.73%. Distance from 52-week low is 28.95% and -17.01% from its 52-week high. The company has generated returns on investments over the last 12 months (-16.31%).
The EPS is expected to shrink by -17.81% this year.
Bio-Rad Laboratories Inc. (BIO) Top Institutional Holders
692.0 institutions hold shares in Bio-Rad Laboratories Inc. (BIO), with institutional investors hold 105.82% of the company’s shares. The shares outstanding are 23.42M, and float is at 19.16M with Short Float at 4.91%. Institutions hold 89.29% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 2.37 million shares valued at $648.5 million. The investor’s holdings represent 8.3263% of the BIO Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 1.55 million shares valued at $$423.48 million to account for 5.4372 of the shares outstanding. The other top investors are VERITAS ASSET MANAGEMENT LLP which holds 1.13 million shares representing 3.9582% and valued at over $308.29 million, while STATE STREET CORP holds 3.0153 of the shares totaling 0.86 million with a market value of $234.84 million.
Bio-Rad Laboratories Inc. (BIO) Insider Activity
#####
Bio-Rad Laboratories Inc. disclosed in a document filed with the SEC on Jun 13 ’24 that Crowley Michael (EVP, GBL Commercial Operations) sold a total of 369 shares of the company’s common stock. The trade occurred on Jun 13 ’24 and was made at $281.91 per share for $0.1 million. Following the transaction, the insider now directly holds 6573.0 shares of the BIO stock.
Still, SEC filings show that on Feb 28 ’24, ERNST TIMOTHY S (EVP, General Counsel & Sec) disposed off 2,500 shares at an average price of $330.55 for $0.83 million. The insider now directly holds 3,397 shares of Bio-Rad Laboratories Inc. (BIO).
